Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1

Retrovirology

Volumn 3, Issue , 2006, Pages

  Costa, Luciana J ^a   Chen, Nan ^b   Lopes, Adriana ^a   Aguiar, Renato S ^a   Tanuri, Amilcar ^a   Plemenitas, Ana ^c   Peterlin, B Matija ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS LINKED GENE 2 INTERACTION PROTEIN 1; CD4 ANTIGEN; GAG PROTEIN; NEF PROTEIN; POL PROTEIN; PROTEIN AIP 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MUTANT; NONHUMAN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; WILD TYPE;

AMINO ACID SEQUENCE; ANTIGENS, CD4; BINDING SITES; CARRIER PROTEINS; CELL LINE, TRANSFORMED; CONSENSUS SEQUENCE; GENE PRODUCTS, GAG; GENE PRODUCTS, NEF; HIV-1; HUMANS; MACROPHAGES; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SEQUENCE ALIGNMENT; TRANSPORT VESICLES; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 33746907799     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-33     Document Type: Article

References (72)

1. Anastassopoulou CG, Kostrikis LG: Viral correlates of HIV-1 disease. Curr HIV Res 2005, 3(2):113-132.
2. Vergis EN, Mellors JW: Natural history of HIV-1 infection. Infect Dis Clin North Am 2000, 14(4):809-25, v-vi.
3. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995, 270(5238):988-991.
4. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC: Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995, 332(4):228-232.
5. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992, 258(5090):1938-1941.
6. Birch MR, Learmont JC, Dyer WB, Deacon NJ, Zaunders JJ, Saksena N, Cunningham AL, Mills J, Sullivan JS: An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol 2001, 22(3):263-270.
7. Sawai ET, Hamza MS, Ye M, Shaw KE, Luciw PA: Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef. J Virol 2000, 74(4):2038-2045.
8. Dyer WB, Geczy AF, Kent SJ, McIntyre LB, Blasdall SA, Learmont JC, Sullivan JS: Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. Aids 1997, 11(13):1565-1574.
9. Lundquist CA, Tobiume M, Zhou J, Unutmaz D, Aiken C: Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J Virol 2002, 76(9):4625-4633.
10. Fackler OT, Wolf D, Weber HO, Laffert B, D'Aloja P, Schuler-Thurner B, Geffin R, Saksela K. Geyer M, Peterlin BM, Schuler G, Baur AS: A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells. Curr Biol 2001, 11(16):1294-1299.
11. Choi J, Walker J, Talbert-Slagle K. Wright P, Pober JS, Alexander L: Endothelial cells promote human immunodeficiency virus replication in nondividing memory T cells via Nef-, Vpr-, and T-cell receptor-dependent activation of NFAT. J Virol 2005, 79(17):11194-11204.
12. Miller MD, Warmerdam MT, Gaston I, Greene WC, Feinberg MB: The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994, 179(1):101-113.
13. Geyer M, Peterlin BM: Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Lett 2001, 496(2-3):91-95.
14. Fackler OT, Luo W, Geyer M, Alberts AS, Peterlin BM: Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol Cell 1999, 3(6):729-739.
15. Coleman SH, Van Damme N, Day JR, Noviello CM, Hitchin D, Madrid R, Benichou S, Guatelli JC: Leucine-specific, functional interactions between human immunodeficiency virus type 1 Nef and adaptor protein complexes. J Virol 2005, 79(4):2066-2078.
16. Craig HM, Reddy TR, Riggs NL, Dao PP, Guatelli JC: Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucine-based sorting motif. Virology 2000, 271(1):9-17.
17. Piguet V, Gu F, Foti M, Demaurex N, Gruenberg J, Carpentier JL, Trono D: Nef-induced CD4 degradation: a diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 1999, 97(1):63-73.
18. Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, Greene WC: A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 1998, 8(22):1235-1238.
19. Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, Heard JM, Schwartz O: Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC1 molecules. Immunity 1998, 8(4):483-495.
20. Lu X, Yu H, Liu SH, Brodsky FM, Peterlin BM: Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4. Immunity 1998, 8(5):647-656.
21. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G: HIV-1 Nef downregulates MHC-1 by a PACS-1-and P13K-regulated ARF6 endocytic pathway. Cell 2002, 111(6):853-866.
22. Wang JK, Kiyokawa E, Verdin.E, Trono D: The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci U S A 2000, 97(1):394-399.
23. Pandori MW, Fitch NJ, Craig HM, Richman DD, Spina CA, Guatelli JC: Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J Virol 1996, 70(7):4283-4290.
24. Welker R, Kottler H, Kalbitzer HR, Krausslich HG: Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 1996, 219(1):228-236.
25. Zheng YH, Plemenitas A, Fielding CJ, Peterlin BM: Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc Natl Acad Sci U S A 2003, 100(14):8460-8465.
26. Liao Z, Graham DR, Hildreth JE: Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. AIDS Res Hum Retroviruses 2003, 19(8):675-687.
27. Costa LJ, Zheng YH, Sabotic J, Mak J, Fackler OT, Peterlin BM: Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1. J Virol 2004, 78(10):5311-5323.
28. Fackler OT, d'Aloja P, Baur AS, Federico M, Peterlin BM: Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity. J Virol 2001, 75(14):6601-6608.
29. Stumptner-Cuvelette P, Jouve M, Helft J, Dugast M, Glouzman AS, Jooss K, Raposo G, Benaroch P: Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase. Mol Biol Cell 2003, 14(12):4857-4870.
30. Sanfridson A, Hester S, Doyle C: Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells. Proc Natl Acad Sci U S A 1997, 94(3):873-878.
31. Sandrin V, Cosset FL: Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J Biol Chem 2006, 281(1):528-542.
32. VerPlank L, Bouamr F, LaGrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A 2001, 98(14):7724-7729.
33. Martin-Serrano J, Zang T, Bieniasz PD: HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 2001, 7(12):1313-1319.
34. Stuchell MD, Garrus JE, Muller B, Stray KM, Ghaffarian S, McKinnon R, Krausslich HG, Morham SG, Sundquist WI: The human endosomal sorting complex required for transport (ESCRT-1) and its role in HIV-1 budding. J Biol Chem 2004, 279(34):36059-36071.
35. Stange A, Mannigel I, Peters K, Heinkelein M, Stanke N, Cartellieri M, Gottlinger H, Rethwilm A, Zentgraf H, Lindemann D: Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J Virol 2005, 79(9):5466-5476.
36. Strack B, Calistri A, Craig S, Popova E, Gottlinger HG: AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003, 114(6):689-699.
37. von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, Wang HE, Davis T, He GP, Cimbora DM, Scott A, Krausslich HG, Kaplan J, Morham SG, Sundquist WI: The protein network of HIV budding. Cell 2003, 114(6):701-713.
38. Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD: Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A 2003, 100(21):12414-12419.
39. Morita E, Sundquist WI: Retrovirus budding. Annu Rev Cell Dev Biol 2004, 20:395-425.
40. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Cote M, Rich RL, Myszka DG, Sundquist WI: Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001, 107(1):55-65.
41. Scott A, Gaspar J, Stuchell-Brereton MD, Alam SL, Skalicky JJ, Sundquist WI:Structure and ESCRT-III protein interactions of the MIT domain of human VPS4A. Proc Natl Acad Sci U S A 2005, 102(39):13813-13818.
42. Gruenberg J, Stenmark H: The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 2004, 5(4):317-323.
43. Alexander M, Bor YC, Ravichandran KS, Hammarskjold ML, Rekosh D: Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity. J Virol 2004, 78(4):1685-1696.
44. Cavrois M, Neidleman J, Yonemoto W, Fenard D, Greene WC: HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. Virology 2004, 328(1):36-44.
45. Ross TM, Oran AE, Cullen BR: Inhibition of HIV-1 progeny virion release by cel-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 1999, 9(12):613-621.
46. Lama J, Mangasarian A, Trono D: Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr Biol 1999, 9(12):622-631.
47. Persson B: Bioinformatics in protein analysis. Exs 2000, 88:215-231.
48. Kuiken C, Korber B, Shafer RW: HIV sequence databases. AIDS Rev 2003, 5(1):52-61.
49. Brenner M, Munch J, Schindler M, Wildum S, Stolte N, Stahl-Hennig C, Fuchs D, Matz-Rensing K, Franz M, Heeney J, Ten Haaft P, Swigut T, Hrecka K, Skowronski J, Kirchhoff F: Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques. J Virol 2006, 80(9):4469-4481.
50. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE: Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 1988, 62(8):2578-2586.
51. Pelchen-Matthews A, Kramer B, Marsh M: Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 2003, 162(3):443-455.
52. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, Schwartz O, Benaroch P: HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A 2001, 98(21):12144-12149.
53. Raposo G, Moore M, Innes D, Leijendekker R, Leigh-Brown A, Benaroch P, Geuze H: Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 2002, 3(10):718-729.
54. de Ronde A, Klaver B, Keulen W, Smit L, Goudsmit J: Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology 1992, 188(1):391-395.
55. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, Richman DD: The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994, 179(1):115-123.
56. Alexander L, Du Z, Rosenzweig M, Jung JU, Desrosiers RC: A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol 1997, 71(8):6094-6099,
57. Shapira-Nahor O, Maayan S, Peden KW, Rabinowitz R, Schlesinger M, Alian A, Panet A: Replication of HIV-1 deleted Nef mutants in chronically immune activated human T cells. Virology 2002, 303(1):138-145.
58. Simmons A, Aluvihare V, McMichael A: Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 2001, 14(6):763-777.
59. Varin A, Manna SK, Quivy V, Decrion AZ, Van Lint C, Herbein G, Aggarwal BB: Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis. J Boil Chem 2003, 278(4):2219-2227.
60. Witte V, Laffert B, Rosorius O, Lischka P, Blume K, Galler G, Stilper A, Willbold D, D'Aloja P, Sixt M, Kolanus J, Ott M, Kolanus W, Schuler G, Baur AS: HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. Mol Cell 2004, 13(2):179-190.
61. van't Wout AB, Swain JV, Schindler M, Rao U, Pathmajeyan MS, Mullins JI, Kirchhoff F: Nef induces multiple genes involved in cholesterol synthesis and uptake in human immunodeficiency virus type 1-infected T cells. J Virol 2005, 79(15):10053-10058.
62. Sol-Foulon N, Esnault C, Percherancier Y, Porrot F, Metais-Cunha P, Bachelerie F, Schwartz O: The effects of HIV-1 Nef on CD4 surface expression and viral infectivity in lymphoid cells are independent of rafts. J Biol Chem 2004, 279(30):31398-31408.
63. Mobius W, van Donselaar E, Ohno-Iwashita. Y, Shimada Y, Heijnen HF, Slot JW, Geuze HJ: Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic 2003, 4(4):222-231.
64. Linnemann T, Zheng YH, Mandic R, Peterlin BM: Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV. Virology 2002, 294(2):246-255.
65. Schibeci SD, Clegg AO, Biti RA Sagawa K, Stewart GJ, Williamson P: HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line. Aids 2000, 14(12):1701-1707.
66. Sasaki H, Nakamura M, Ohno T, Matsuda Y, Yuda Y, Nonomura Y: Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc Natl Acad Sci U S A 1995, 92(6):2026-2030.
67. Schiavoni I, Trapp S, Santarcangelo AC, Piacentini V, Pugliese K, Baur A, Federico M: HIV-1 Nef enhances both membrane expression and virion incorporation of Env products. A model for the Nef-dependent increase of HIV-1 infectivity. J Biol Chem 2004, 279(22):22996-23006.
68. Blom J, Nielsen C. Rhodes JM: An ultrastructural study of HIV-infected human dendritic cells and monocytes/macrophages. Apmis 1993, 101(9):672-680.
69. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59(2):284-291.
70. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, et al.: Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor I-treated monocytes. J Exp Med 1988, 167(4):1428-1441.
71. Alizon M, Wain-Hobson S, Montagnier L, Sonigo P: Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell 1986, 46(1):63-74.
72. Akari H, Uchiyama T, Fukumori T, Iida S, Koyama AH, Adachi A: Pseudotyping human Immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef. J Gen Virol 1999, 80 (Pt 11):2945-2949.